Number of the records: 1
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
- 1.0584089 - BTÚ 2025 RIV CH eng J - Journal Article
Kafkova, L. R. - Mierzwicka, Joanna Maria - Chakraborty, P. - Jakubec, P. - Fischer, O. - Škarda, J. - Malý, Petr - Raška, M.
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.
Frontiers in Immunology. Roč. 15, FEB 7 2024 (2024), č. článku 1342086. ISSN 1664-3224. E-ISSN 1664-3224
Institutional support: RVO:86652036
Keywords : PD-1 * immune checkpoint * PD-L1 * CELL LUNG-CANCER
OECD category: Immunology
Impact factor: 5.7, year: 2023 ; AIS: 1.693, rok: 2023
Method of publishing: Open access
Result website:
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1342086/fullDOI: https://doi.org/10.3389/fimmu.2024.1342086
Permanent Link: https://hdl.handle.net/11104/0353420
Number of the records: 1